Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/VA/Alexandria
Updated September 2026 from ClinicalTrials.gov

Paid Clinical Trials in Alexandria, VA

Studies commonly pay $75 to $4,500 per completed study

2,292 clinical trials are currently recruiting participants within 30 miles of Alexandria. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

2,292studies recruiting
9+research centers nearby
6condition categories
Live from the NIH registry

Studies recruiting near Alexandria right now

Top 25 of 2,292 recruiting studies, sorted by proximity — each links to its official registry page

Collection and Distribution of Blood Components From Healthy Donors for In Vitro Research Use

Blood Donors, Research Subjects N/A Observational 5,000 participants sought
National Institutes of Health Clinical Center — Bethesda, Maryland (11.2 mi) · Sponsor: National Institutes of Health Clinical Center (CC)
See eligibility & contact on ClinicalTrials.gov (NCT00001846)

Observational Study of Cardiac Arrhythmias During Treatment With BTK Inhibitors or Venetoclax

Chronic Lymphocytic Leukemia (CLL), Waldenstr(SqrRoot)(Delta)m s Macroglobulinemia N/A Observational 135 participants sought
National Institutes of Health Clinical Center — Bethesda, Maryland (11.2 mi) · Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
See eligibility & contact on ClinicalTrials.gov (NCT05724121)

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

B Acute Lymphoblastic Leukemia Phase 2 Interventional 222 participants sought
MedStar Georgetown University Hospital — Washington D.C., District of Columbia (5.9 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06124157)

A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies

KRAS G12C Mutation, KRAS G12S Mutation Phase 1 Interventional 140 participants sought
NEXT Virginia, LLC — Fairfax, Virginia (12.0 mi) · Sponsor: Kumquat Biosciences Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06720987)

Doxycycline Prophylaxis for Prevention of Sexually Transmitted Infections

Gonorrhea, Chlamydia Phase 4 Interventional 760 participants sought
Children's National Medical Center — Washington D.C., District of Columbia (5.9 mi) · Sponsor: Westat
See eligibility & contact on ClinicalTrials.gov (NCT06738407)

A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas

Triple Negative Breast Cancer, HER2-negative Breast Cancer Phase 1 Interventional 96 participants sought
Dren Investigational Site — Fairfax, Virginia (12.0 mi) · Sponsor: Dren Bio
See eligibility & contact on ClinicalTrials.gov (NCT06999187)

A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease, GM1 Gangliosidosis or GM2 Gangliosidosis

Niemann-Pick Type C Disease, GM1 Gangliosidosis Phase 3 Interventional 147 participants sought
Lysosomal Rare Disorders Research and Treatment Center — Fairfax, Virginia (12.0 mi) · Sponsor: Azafaros B.V.
See eligibility & contact on ClinicalTrials.gov (NCT07054515)

Phase 1a/b Study of ZL-6201 Safety, PK, and Preliminary Efficacy in Sarcoma and Selected Tumors

Solid Tumors, Sarcomas Phase 1 Interventional 180 participants sought
Zai Lab Site 02006 — Fairfax, Virginia (12.0 mi) · Sponsor: Zai Lab (Shanghai) Co., Ltd.
See eligibility & contact on ClinicalTrials.gov (NCT07374848)

A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated

Diabetic Macular Edema Phase 1, Phase 2 Interventional 49 participants sought
Emerson Clinical Research Institute — Falls Church, Virginia (6.4 mi) · Sponsor: Boehringer Ingelheim
See eligibility & contact on ClinicalTrials.gov (NCT07553429)

Tissue Collection for Studies of Lymph Cancer

Hodgkin Disease, Lymphoma, Non-Hodgkin N/A Observational 1,295 participants sought
National Institutes of Health Clinical Center — Bethesda, Maryland (11.2 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT01676805)

Recruitment and Characterization of Healthy Research Volunteers for NIMH Intramural Studies

Healthy Volunteer N/A Observational 2,000 participants sought
National Institutes of Health Clinical Center — Bethesda, Maryland (11.2 mi) · Sponsor: National Institute of Mental Health (NIMH)
See eligibility & contact on ClinicalTrials.gov (NCT03304665)

Mechanism of Action Underlying Ketamine's Antidepressant Effects: The AMPA Throughput Theory in Patients With Treatment-Resistant Major Depression

Depression, Major Depressive Disorder Phase 1 Interventional 70 participants sought
National Institutes of Health Clinical Center — Bethesda, Maryland (11.2 mi) · Sponsor: National Institute of Mental Health (NIMH)
See eligibility & contact on ClinicalTrials.gov (NCT03973268)

PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma

High Grade Glioma, Diffuse Intrinsic Pontine Glioma Phase 2 Interventional 120 participants sought
Children's National Medical Center — Washington D.C., District of Columbia (5.9 mi) · Sponsor: Nationwide Children's Hospital
See eligibility & contact on ClinicalTrials.gov (NCT05096481)

Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC) Phase 1 Interventional 604 participants sought
NEXT Oncology Virginia — Fairfax, Virginia (12.0 mi) · Sponsor: Revolution Medicines, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06040541)

Connect to Baby: A Pilot Study of a Parenting and Coparenting Program

Parenting N/A Interventional 200 participants sought
Child Development and Social Policy Lab — Washington D.C., District of Columbia (5.9 mi) · Sponsor: Georgetown University
See eligibility & contact on ClinicalTrials.gov (NCT06179576)

A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)

Lymphoma, Large B-Cell, Diffuse Phase 2 Interventional 594 participants sought
Georgetown University Medical Center ( Site 0117) — Washington D.C., District of Columbia (5.9 mi) · Sponsor: Merck Sharp & Dohme LLC
See eligibility & contact on ClinicalTrials.gov (NCT06890884)

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

PIK3CA Mutation, HER2- Negative Breast Cancer Phase 3 Interventional 540 participants sought
Georgetown University Medical Center — Washington D.C., District of Columbia (5.9 mi) · Sponsor: Relay Therapeutics, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06982521)

Telehealth for Sleep Apnea: Effectiveness, Implementation, and Cost in the Military Health System

Obstructive Sleep Apnea (OSA) N/A Interventional 160 participants sought
Uniformed Services University — Bethesda, Maryland (11.2 mi) · Sponsor: Uniformed Services University of the Health Sciences
See eligibility & contact on ClinicalTrials.gov (NCT07121452)

Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma

Urothelial Cancer, Bladder Cancer Phase 2, Phase 3 Interventional 630 participants sought
Research Site — Largo, Maryland (14.8 mi) · Sponsor: Daiichi Sankyo
See eligibility & contact on ClinicalTrials.gov (NCT07129993)

Blood Sampling for Research Related to Sickle Cell Disease

Sickle Cell Trait, Sickle Cell Disease N/A Observational 250 participants sought
National Institutes of Health Clinical Center — Bethesda, Maryland (11.2 mi) · Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
See eligibility & contact on ClinicalTrials.gov (NCT00542230)

A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)

Ulcerative Colitis, Ulcerative Colitis Chronic Phase 3 Interventional 150 participants sought
Pediatric Specialists of Virginia — Fairfax, Virginia (12.0 mi) · Sponsor: Eli Lilly and Company
See eligibility & contact on ClinicalTrials.gov (NCT04844606)

PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma

Metastatic Colorectal Cancer (Mcrc), Intrahepatic Cholangiocarcinoma (Icc) Phase 2 Interventional 70 participants sought
National Institutes of Health Clinical Center — Bethesda, Maryland (11.2 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05286814)

The Purpose of This Research Study is to See if Combining Gemcitabine, Cisplatin and Durvalumab Chemotherapy Treatments With a Direct Tumor Therapy Yittrium-90 (Y-90) Will Work Better Together to Shrink Tumors and Control Cancer

Intrahepatic Cholangiocarcinoma Phase 2 Interventional 16 participants sought
Keary Janet — Fairfax, Virginia (12.0 mi) · Sponsor: Inova Health Care Services
See eligibility & contact on ClinicalTrials.gov (NCT05422690)

Childhood-Onset Essential Hypertension Natural History Study

Hypertension, Essential Hypertension N/A Observational 2,300 participants sought
National Institutes of Health Clinical Center — Bethesda, Maryland (11.2 mi) · Sponsor: National Human Genome Research Institute (NHGRI)
See eligibility & contact on ClinicalTrials.gov (NCT06778239)
Actively enrolling

Studies you may be able to join near Alexandria

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

Research study for alcohol-related liver damage

Enrolling US adults aged 18 to 70 with alcohol-induced liver damage and a history of heavy drinking. Not open to people with a recent stroke, heart attack, dialysis, or who take blood thinners.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Research study for severe chronic itching

Enrolling adults aged 18 to 90 who have had chronic itching for six months or longer. Not open to itching caused by atopic dermatitis, psoriasis, chronic kidney disease, notalgia paresthetica or medication, nor to people with an autoimmune condition such as lupus, Crohn's disease, ulcerative colitis or rheumatoid arthritis.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Research study for heart failure

This study is enrolling adults in eligible areas of the United States who have been diagnosed with heart failure. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Research studies for chronic kidney disease

This research platform is enrolling Black and African American adults in eligible areas who have been diagnosed with chronic kidney disease. Compensation may be available. The study team confirms eligibility before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Research study for bladder problems after spinal cord injury

This study is enrolling US adults aged 18 to 75 living with chronic involuntary bladder leakage caused by a spinal cord injury, for research including investigational gene therapy approaches. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Alexandria

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

MD Medical Research

★ 4.9
6357 Oxon Hill Rd Fl 2, Oxon Hill, MD 20745
(301) 329-2612
"Maluu is so kind and professional ❤️"
— Tiffany West, 5★

Emerson Clinical Research Institute

★ 4.7
1718 Connecticut Ave NW, Washington, DC 20009
(202) 239-0777
"10/10 Vengan a Emerson Clinic que Wendy y Eliana son amables y tienen tanta paciencia para atenderlos. La clínica tiene recursos que ayudan y el doct…"
— Luis Mejia, 5★

NIH Clinical Center

★ 4.6
10 Center Dr, Bethesda, MD 20892
(301) 496-4000
"Fantastic staff. Very professional and welcoming."
— Paul, 5★

Millennium Clinical Trials

3801 Fairfax Dr #32, Arlington, VA 22203
(703) 527-8100

Terrain Clinic

★ 5.0
113 Oronoco St, Alexandria, VA 22314
(703) 269-0589

National Center for Health Research

1001 Connecticut Ave NW #1100, Washington, DC 20036
(202) 223-4000

Velocity Clinical Research

★ 5.0
4910 Massachusetts Ave NW Ste. 315, Washington, DC 20016
(202) 998-3833
"Very great staff and respectful"
— Reginald Simms, 5★

Foundation For Physical Therapy Research

3030 Potomac Ave, Alexandria, VA 22305
(800) 875-1378

Inova Schar Cancer Clinical Trials (A dept of Fairfax Hospital)

8081 Innovation Park Dr 8th floor, Fairfax, VA 22031
(571) 472-4724

Clinical trials in Alexandria: what's recruiting

The Alexandria area currently has 2,292 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Alexandria, the most active research areas are:

  • Cancer & Oncology13 studies
  • Liver & Kidney2 studies
  • Diabetes & Metabolism1 studies
  • Brain & Mental Health1 studies
  • Immune & Skin1 studies

Every listing shows the study phase, the recruiting site and its distance from Alexandria, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Alexandria

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Alexandria participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Alexandria pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
Do I need to be sick to join a clinical trial in Alexandria?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
Are clinical trials in Alexandria safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
What is the difference between a research center and a hospital study in Alexandria?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Alexandria typically complete one or two studies per year.

Paid clinical trials near Alexandria

Other metros within reach

Arlington, VA2,330 Washington, DC2,362 Fredericksburg, VA35 Baltimore, MD1,652 Frederick, MD254 Hagerstown, MD107 York, PA443 Richmond, VA599

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Alexandria Severe Chronic Pruritus in Alexandria Heart Failure in Alexandria Chronic Kidney Disease (HealthMatch) in Alexandria Bladder Issues Due To Spinal Cord Injury in Alexandria All conditions

More of VA

Arlington2,330 Richmond599 Chesapeake399 Virginia Beach398 Norfolk398 Newport News377 Roanoke191 Fredericksburg35

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts